Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | PPARA | Q07869 | 5/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | IGF1R | P08069 | 2/20 | 0.45 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL804472 | 0.81 | CYP3A4 (0.50) | KMT2AMEN1L3MBTL1CYP3A4NPC1 | |
| SCHEMBL804703 | 0.81 | CYP3A4 (0.74) | KMT2AMEN1CYP2C19CYP2C9CYP3A4 | |
| SCHEMBL1304683 | 0.77 | PPARA (0.61) | KMT2AMEN1PPARAPPARGCYP2C19 | |
| SCHEMBL14976928 | 0.76 | NPC1 (0.67) | KMT2AMEN1NPC1KDM4E | |
| SCHEMBL16265333 | 0.76 | PPARA (0.54) | KMT2AMEN1PPARAPPARGCYP2C19 | |
| SCHEMBL805971 | 0.75 | PPARA (0.61) | KMT2AMEN1PPARAPPARGCYP2C19 | |
| SCHEMBL16303954 | 0.75 | PPARA (0.61) | KMT2AMEN1PPARAPPARGCYP2C19 | |
| SCHEMBL16302943 | 0.73 | POLB (0.46) | KMT2AMEN1GAAPPARAPPARG | |
| SCHEMBL806021 | 0.73 | KMT2A (0.59) | KMT2AMEN1PPARAPPARGCYP2C19 | |
| SCHEMBL11752834 | 0.73 | PPARA (0.59) | KMT2AMEN1GAAPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040553-B2 | Phenoxyisobutyric acid compounds and method of synthesis | Cell Viable Corporation (US) | 2015-05-26 | — | — | US | disclosed |
| US-9040553-B2 | Phenoxyisobutyric acid compounds and method of synthesis | Cell Viable Corporation (US) | 2015-05-26 | — | — | US | disclosed |
| US-20140350045-A1 | PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS | LALEZARI IRAJ (US) | 2014-11-27 | — | — | US | disclosed |
| US-20140350045-A1 | PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS | LALEZARI IRAJ (US) | 2014-11-27 | — | — | US | disclosed |
| US-20120071502-A1 | Novel phenoxyisobutyric acid compounds and methods for synthesis | Cell Viable Corporation (US) | 2012-03-22 | — | — | US | disclosed |
| US-20120071502-A1 | Novel phenoxyisobutyric acid compounds and methods for synthesis | Cell Viable Corporation (US) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350045-A1 | PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS | AGER, BPGM, PDXK | KMT2A 1910/4885MEN1 2478/4885GAA 94/4885 |
| US-20120071502-A1 | Novel phenoxyisobutyric acid compounds and methods for synthesis | AGER, BPGM, PDXK | KMT2A 2270/4885MEN1 2627/4885GAA 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.